Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.13 EUR | +0.49% | +5.90% | -17.40% |
Apr. 26 | Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 03 | Valbiotis: launch of Valbiotis PRO Cholesterol in May | CF |
Chart calendar VALBIOTIS
Upcoming events on VALBIOTIS
Past events on VALBIOTIS
2024-04-28 | Q4 2023 Earnings Release After hours |
2023-09-27 | Q2 2023 Earnings Release |
2023-05-02 03:30 am | Annual General Meeting |
2023-03-15 12:40 pm | Q4 2022 Earnings Release |
2022-11-03 | American learned society for liver diseases Conference |
2022-09-29 | Interim 2022 Earnings Release |
2022-05-05 11:00 am | Shareholders Meeting |
2022-03-15 12:40 pm | FY 2021 Earnings Release |
2021-09-30 01:35 am | Interim 2021 Earnings Release |
2021-05-27 11:00 am | Shareholders Meeting |
2021-04-10 | ESH-ISH Meeting - TOTUM-854 |
2021-03-17 12:40 pm | FY 2020 Earnings Release |
2021-01-10 | J.P. Morgan Healthcare Conference |
2020-09-29 | Interim 2020 Earnings Release |
2020-04-21 01:35 am | FY 2019 Earnings Release |
2019-09-15 | European Association for the Study of Diabetes Meeting |
2019-06-23 | First HealthTech Investor Day |
2019-06-06 | American Diabetes Association Meeting |
2019-04-03 | FY 2018 Earnings Release (Projected) |
2019-01-06 | J.P. Morgan Healthcare Conference |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 1,51 0,00 - | 1,91 1,90 0.68% | 5,10 6,57 -22.35% | 2,69 3,75 -28.19% | 2,81 2,67 5.52% | 6,81 6,17 10.42% |
EBITDA Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -2,37 -2,30 -3.04% | -7,53 -5,10 -47.73% | -11,2 -10,6 -5.42% | 0,00 -9,00 - |
EBIT Million EUR | Released Forecast Spread | -4,88 -6,70 27.22% | -5,16 -5,70 9.53% | -3,41 -2,58 -32.05% | -8,48 -5,65 -50% | -12,0 -12,1 0.34% | -7,18 -10,2 29.61% |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -3,83 -3,68 -4.05% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
Net income Million EUR | Released Forecast Spread | -4,97 -6,70 25.87% | -5,50 -5,70 3.44% | -3,83 -2,40 -59.54% | -8,68 -5,45 -59.28% | -12,3 -12,2 -1.19% | -7,37 -10,3 28.7% |
EPS EUR | Released Forecast Spread | 0,00 0,00 - | -1,18 -0,78 -50.5% | -0,52 -0,34 -53.07% | -0,94 -0,77 -22.81% | -1,21 -1,20 -1.26% | 0,00 -0,94 - |
Announcement Date | 08/03/19 | 21/04/20 | 16/03/21 | 15/03/22 | 15/03/23 | 26/04/24 |
Past sector events for VALBIOTIS
2024-05-03 07:00 am | GH RESEARCH PLC: Q1 2024 Earnings Release |
2024-05-02 04:05 pm | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
2024-05-02 04:05 pm | ZYMEWORKS INC.: Q1 2024 Earnings Release |
2024-05-02 04:02 pm | ARDELYX, INC.: Q1 2024 Earnings Release |
2024-05-02 04:01 pm | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-02 04:01 pm | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
2024-05-02 04:00 pm | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
2024-05-02 11:00 am | GENMAB A/S: Q1 2024 Earnings Release |
2024-05-02 07:00 am | GERON CORPORATION: Q1 2024 Earnings Release |
2024-05-02 07:00 am | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALVAL Stock
- Calendar VALBIOTIS